| Ident. | Authors (with country if any) | Title |
|---|
| 000069 (2013) |
Erwan Bézard [France] ; C. Warren Olanow [États-Unis] ; José A. Obeso [Espagne] | Levodopa–induced dyskinesias in the absence of nigrostriatal degeneration |
| 000620 (2009) |
David A. Price [États-Unis] ; Alex A. Martinez [États-Unis] ; Alexandre Seillier [États-Unis] ; Wouter Koek [États-Unis] ; Yolanda Acosta [États-Unis] ; Elizabeth Fernandez [États-Unis] ; Randy Strong [États-Unis] ; Beat Lutz [Allemagne] ; Giovanni Marsicano [France] ; James L. Roberts [États-Unis] ; Andrea Giuffrida [États-Unis] | WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease |
| 000706 (2009) |
Nadja Van Camp [Belgique, France] ; Ines Blockx [Belgique] ; Marleen Verhoye [Belgique] ; Cindy Casteels [Belgique] ; Frea Coun [Belgique] ; Alexander Leemans [Royaume-Uni, Pays-Bas] ; Jan Sijbers [Belgique] ; Veerle Baekelandt [Belgique] ; Koen Van Laere [Belgique] ; Annemie Van Der Linden [Belgique] | Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract |
| 000880 (2007) |
Camila L. Zold [Argentine] ; Bérangère Ballion [France] ; Luis A. Riquelme [Argentine] ; François Gonon [France] ; M. Gustavo Murer [Argentine] | Nigrostriatal lesion induces D2‐modulated phase‐locked activity in the basal ganglia of rats |
| 000E53 (2001) |
Sorin Breit ; Rabia Bouali-Benazzouz ; Alim-Louis Benabid [France] ; Abdelhamid Benazzouz [France] | Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat |
| 000E95 (2001) |
Guillaume Lucas [France] ; Vincenzo Di Matteo [Italie] ; Philippe De Deurwaerdère [France] ; Grégory Porras [France] ; Raúl Martín-Ruiz [Espagne] ; Francesc Artigas [Espagne] ; Ennio Esposito [Italie] ; Umberto Spampinato [France] | Neurochemical and electrophysiological evidence that 5‐HT4 receptors exert a state‐dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function |
| 001056 (2000) |
Z. G. Ni [France] ; D. M. Gao [République populaire de Chine] ; A. L. Benabid [France] ; A. Benazzouz [France] | Unilateral lesion of the nigrostriatal pathway induces a transient decrease of firing rate with no change in the firing pattern of neurons of the parafascicular nucleus in the rat |
| 001105 (2000) |
Etienne C. Hirsch [France] ; Céline Périer [France] ; Gaël Orieux [France] ; Chantal François [France] ; Jean Féger [France] ; Jér Ome Yelnik [France] ; Miquel Vila [France] ; Richard Levy [France] ; Eduardo S. Tolosa [Espagne] ; Concepcio Marin [Espagne] ; M. Trinidad Herrero [Espagne] ; José A. Obeso [Espagne] ; Yves Agid [France] | Metabolic effects of nigrostriatal denervation in basal ganglia |
| 001135 (2000) |
Pascal Barnéoud [France] ; Eric Descombris [France] ; Nadine Aubin [France] ; Djoher N. Abrous [France] | Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system |
| 001178 (2000) |
Erwan Bezard [France] ; Mohamed Jaber [France] ; François Gonon [France] ; Alain Boireau [France] ; Bertrand Bloch [France] ; Christian E. Gross [France] | Adaptive changes in the nigrostriatal pathway in response to increased 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced neurodegeneration in the mouse |
| 001371 (1999) |
H. Becq [France] ; O. Bosler [France] ; M. Geffard [France] ; A. Enjalbert [France] ; J. P. Herman [France] | Anatomical and functional reconstruction of the nigrostriatal system in vitro: Selective innervation of the striatum by dopaminergic neurons |
| 001511 (1998) |
Cristina Murer [France] ; Gustavo Dziewczapolski [Argentine] ; Liliana B. Menalled [Argentine] ; M. Carmen García [Argentine] ; Yves Agid [France] ; Oscar Gershanik [Argentine] ; Rita Raisman-Vozari [France] | Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions |
| 001918 (1995) |
Philippe Anglade [France] ; France Javoy-Agid [France] ; Yves Agidm [France] ; Etienne C. Hirsch [France] ; Shigeru Tsuji [France] | Plasticity of nerve afferents to nigrostriatal neurons in parkinson's disease |
| 001946 (1995) |
R. Levy [France] ; M. T. Herrero [France, Espagne] ; M. Ruberg [France] ; J. Villares [France] ; B. Faucheux [France] ; J. Guridi [Espagne] ; J. Guillen [Espagne] ; M. R. Luquin [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [France] ; E. C. Hirsch [France] | Effects of Nigrostriatal Denervation and L‐Dopa Therapy on the GABAergic Neurons of the Striatum in MPTP‐treated Monkeys and Parkinson's Disease: An In Situ Hybridization Study of GAD67 mRNA |
| 001A32 (1994) |
Astrid C. E. Linthorst [Pays-Bas] ; Paul L. M. Van Giersbergen [France] ; Mitzi Gras [Pays-Bas] ; Dirk H. G. Versteeg [Pays-Bas] ; Wybren De Jong [France] | The nigrostriatal dopamine system: role in the development of hypertension in spontaneously hypertensive rats |
| 001C69 (1992) |
M. Chritin [France] ; M. Savasta [France] ; F. Mennicken [France] ; A. Bal [France] ; D. N. Abrous [France] ; M. Le Moal [France] ; C. Feuerstein [France] ; J. P. Herman [France] | Intrastriatal Dopamine‐rich Implants Reverse the Increase of Dopamine D2 Receptor mRNA Levels Caused by Lesion of the Nigrostriatal Pathway: A Quantitative In Situ Hybridization Study |
| 001D76 (1991) |
M. Savasta [France] ; F. Mennicken [France] ; M. Chritin [France] ; D. N. Abrous [France] ; C. Feuerstein [France] ; M. Le Moal [France] ; J. P. Herman [France] | Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: An autoradiographic study |
| 001E61 (1990) |
P. Apicella [France] ; E. Trouche [France] ; A. Nieoullon [France] ; E. Legallet [France] ; N. Dusticier [France] | Motor impairments and neurochemical changes after unilateral 6-hydroxydopamine lesion of the nigrostriatal dopaminergic system in monkeys |
| 001E66 (1990) |
R. Raisman-Vozari [France] ; J.-A. Girault [États-Unis] ; S. Moussaoui [France] ; C. Feuerstein [France] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Yves Agid [France] | Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man |
| 002335 (1981) |
A. Chéramy [France] ; V. Leviel [France] ; F. Daudet [France] ; B. Guibert [France] ; M. F. Chesselet [France] ; J. Glowinski [France] | Involvement of the thalamus in the reciprocal regulation of the two nigrostriatal dopaminergic pathways |
| 002336 (1981) |
V. Leviel [France] ; M. F. Chesselet [France] ; J. Glowinski [France] ; A. Chéramy [France] | Involvement of the thalamus in the asymmetric effects of unilateral sensory stimuli on the two nigrostriatal dopaminergic pathways in the cat |
